limited-stage small cell lung cancer
Conditions
Interventions
Conventional medicine group:No
Integrated Chinese and conventional medicine Group:No
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years. 2. Patients diagnosed as limited-stage small cell lung cancer by pathology received first-line treatment (standard chemoradiotherapy). 3. The expected survival >= 3 months. 4. ECOG score for physical condition was 0-2. 5. Voluntarily participated in the study and signed the informed consent. 6. >= 4 cycles of chemotherapy, efficacy evaluation was effective (SD, PR or CR).
Exclusion criteria
Exclusion criteria: 1. Diagnosed with serious diseases of heart, liver, kidney and hematopoietic system. 2. Patients known to be allergic to study medication. 3. Children, pregnant women, mentally disordered patients and patients with other malignant tumors. 4. Patients undergoing other drug trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PFS(progress-free survival);OS(overall survival); | — |
Secondary
| Measure | Time frame |
|---|---|
| PPS(post-progression survival);Survival rate;Recurrence and metastasis rate;Tumor markers;Evaluation of TCM(Traditional Chinese Medicine) symptoms;Quality of life evaluation;ECOG/PS(Eastern Cooperative Oncology Group performance status);Safety indicators; | — |
Countries
China
Contacts
Public ContactLi Conghuang
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Outcome results
None listed